Introduction
High-throughput, phenotypic (based on observable material or behavioral properties) screening of small molecules in cells provides a powerful means to interface synthetic organic chemistry and cell biology. Because these assays can report on an overall cellular state, they provide an unbiased, system-based approach to exploring cellular pathways and processes. This situation differs from typical drug-screening efforts aimed at altering the function of a single, pre-selected target protein without immediate concern for the effect of compounds within cells. The approach described here emulates the logic of a classical (forward) genetic screen [1] , but differs from genetics in that it relies upon small molecules, rather than mutations, to modulate conditionally the circuitry of biological processes [2, 3] (see also http//www-schreiber.chem.harvard.edu/).
We applied this chemical genetic approach to an essential cellular process, seeking to identify small molecules that alter the progression of cells through the mammalian celldivision cycle. In particular, we focused on those pathways essential to chromosome segregation during mitosis (Figure la) [4] [5] [6] [7] [8] . Compounds were initially screened using a high-throughput cytoblot assay, in which an antibody is used to detect a post-translational modification characteristic of the process of interest (Figure 1 b) [9] . This assay used TG-3, a monoclonal antibody (mAb) that recognizes a form of the protein nucleolin specifically phosphorylated during mitosis, to report indirectly on the progress of cells through mitosis [10] [11] [12] . Accordingly, small molecules that increase the reactivity of this mAb in cells are likely to cause the arrest of cells in the mitotic state (e.g., [13] ). As many compounds that have previously been shown to arrest cells in mitosis directly affect the puiymcrlzaton Uf"say polymerization of a and ~ tubulin (the heterodimeric subunits of microtubules), and thereby alter the microtubule dynamics of the mitotic spindle [14, 15] (Figure la) , compounds that scored positively in this initial assay were subsequently tested in an ill vitro tubulin polymerization assay (Figure 1b) . To classify further compounds on the basis of their phenotypic effects, fluorescence microscopy was used to visualize the distribution of microtubules, actin and chromatin in cells treated with compounds of interest.
Results
Two rounds of screening of a 16,320 compound library (Diverse E set, Chembridge Corp.) at -20-50 IlM resulted in the identification of 139 compounds that increased (at least 2.5 times) the amount of phosphorylated nucleolin in asynchronous A549 lung epithelial cells, as measured by reactivity of the TG-3 mAb [9] . The structure of each of the 139 compounds, along with an approximate estimation of their potency, will be posted on our website at http://iccb.med.harvard.edu. An example of these data is shown in Figure 2a and b. These 139 compounds had no effect on the ill vitro polymerization of actin (J. Peterson, unpublished observations), the ill vitro degradation of a cyclin B-Iuciferase fusion protein in XetlOPUS extracts (R.W.K., unpublished observations) or the activation of a growth-factor-dependent reporter gene (B. Stockwell, unpublished observations), suggesting some level of specificity in their target interactions.
The ability of the 139 compounds to affect directly the polymerization of purified bovine brain tubulin was assessed using an ill vitro tubulin polymerization assay. As summarized in Figure 2c , 52 compounds (group 1) destabilized microtubules (data not shown) and one compound (group Il) stabilized microtubules when assayed in this format. The remaining 86 compounds (group Ill) had no observable effect, and therefore appear to interfere with progression through mitosis by mechanisms not involving modulation of microtubule polymerization dynamics (see below). 
Colurnn
Example and summary of screening data for small molecules that perturb the mitotic machinery of mammalian cells. Compounds (-50 ~M) were pin-transferred into wells of a 384-well plate containing 50 ~I media and -4000 cells. After a 24 h incubation, cells were fixed and processed for a TG-3 cytoblot assay as described previously [9] . (a) Results of a TG-3 cytoblot assay on 314 of the 16,320 compounds screened. (b) Five compounds (I-V) were chosen from within this set and the values of their maximum fold-activation in TG-3 mAb reactivity (relative to a DMSO control) after retesting at -1 00 ~M are in green. As a positive control, column 1, rows 1-8 contained nocodazole (332 nM) and as a negative control, column 1, rows [9] [10] [11] [12] [13] [14] [15] [16] Group I: colchicine-like small molecules that destabilize microtubules
On the basis of their effectiveness in the cytoblot assay, the most potent antimitotic compounds identified are those compounds that destabilized microtubules ill vitro (group I). These compounds include members of structural types 1-8 ( Figure 3a) . Compound la is a wellknown microtubule-destabilizer, nocodazole [14] . This compound was twice present within the library, as was analog lb.
The same three-ring skeleton is shared by six out of the 52 group I compounds (Za-f), although their dose response in the cytoblot assay varied (Figure 3a) . This variation provided an opportunity to correlate the results obtained from the cytoblot and tubulin polymerization assays with the cellular effects of each compound. Cells were treated with compounds at a given concentration (see Figure 4) , fixed, and the distribution of microtubules and chromatin was visualized using fluorescence microscopy ( Figure 5 ). Compounds with effective concentrations required for half-maximal signal (EC so ) in the range of 0.5-1.0 ~M in the cytoblot assay (e.g. Zb, Figure 4b) completely destabilized microtubules in both interphase (e.g., Figure 5d ) and mitotic (data not shown) cells, resulting in randomly arrayed mitotic chromosomes.
Compounds having an EC so in the range of 5-10 ~M (e.g. 2e) either partially destabilized interphase microtubules or had no visible effect on the microtubule cytoskeleton (data not shown). Regardless of their effects on interphase cells, these less potent compounds still caused abnormal mitotic spindle structures and altered chromosome distribution.
Fluorescence microscopy of cells treated with high concentrations (-SO ~M) of 23 structural analogs of Z (Diverse E set, Chembridge Corp.), which either scored negatively in the cytoblot assay or were not within group I, identified an additional 11 small molecules (Zg-q) that destabilized microtubules in cells ( Figure 3a) . As compounds Zg, Zi, Zo and Zq were among those considered to be in group Ill, these compounds define a subset of group III that may also directly target tubulin, but may bind weakly and thus may be ineffective at targeting purified tubulin in an it! vitro assay. For example, although compound Zg had no effect on the stability of with the normal bipolar spindle and alignment of chromosomes (Figure 6a ,b). These results, and the results described above, highlight the sensitivity of the mitotic spindle and checkpoint to relatively weak perturbations 
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in microtubule dynamics that otherwise have no observable effect on interphase cells [6, 15] . Although this sensitivity is remarkable, it is not unexpected given previous work with low doses of vinca alkaloids and taxol [16] .
Group 11: taxoHike small molecules that stabilize microtubules
Compounds in group I share functional properties with many synthetic compounds and natural products that disrupt the interactions between the alp tubulin subunits of microtubules, whereas small molecules having the opposite effect of stabilizing these interactions (e.g., taxol [17] , discodermolide [18, 19] ) are more rare [14, 20] . On the basis of the results from the visual assay of the effects of compounds on the ill vitro polymerization of purified bovine brain tubulin (Figure 7 ), compound 9a (group II; Figure 3b ), here named synstab A (for synthetic stabilizer), stabilizes microtubules polymerized from purified bovine brain tubulin (Figure 7b ), as does taxol (Figure 7c) . As a second means of confirming the stabilizing effects of synstab A, we measured the change in the optical density upon the polymerization of a solution of tubulin in the presence of synstab A. In agreement with the visual assay, the addition of an excess of synstab A (lOO IlM) increased the rate and overall magnitude of the increase in optical density because of polymer-dependent light scattering, as compared with the addition of dimethyl sulfoxide Figure 7d ). Because this increase in optical density reflects increased stability of microtubules in the absence of microtubule-associated proteins and other cellular factors, synstab A therefore stabilizes microtubules through a direct interaction with tubulin proteins.
To ensure that the observed increase in optical density was because of the formation of microtubules and not other structures, tubulin samples after polymerization were negatively stained and visualized under low (x 4000) and high magnification (x 50,000) using electron microscopy. As for samples treated with taxol (data not shown), there was a significant increase in the amount of microtubules observed in the presence of synstab A (Figure 8a ) relative to treatment with DMSO (data not shown). Microtubules that were formed showed a longitudinal axis of symmetry and were of varying lengths. Under high magnification (Figure 8b ), striations indicative of protofilament boundaries were observed and the overall morphology was indistinguishable from that of microtubules formed in the presence of either taxol or DMSO (data not shown). Thus, synstab A's mechanism of microtubule stabilization il1 vitro does not involve a dramatic rearrangement of microtubule structure, as might be expected to occur if it caused a nonspecific aggregation of tubulin.
In the cytoblot assay, synstab A had an EC so of 1O-1s)lM (Figure 4b) , whereas a compound lacking the sulphonamide group over a similar range of concentrations had no effect (data not shown). The value of this cytoblot EC so is -SOD-fold greater than that observed with taxol (Figure 4a) . Consistent with the stabilizing effects of synstab A on purified microtubules (Figure 7) , staining of kidney epithelial cells (BS-C-l) showed that synstab A treatment leads to microtubule bundles in interphase cells (Figure se,h ) and to disrupted spindles and abnormal chromosome distribution in mitotic cells (data not shown). Testing of a series of 23 analogs of synstab A (Diverse E set, Chembridge Corp.), up to concentrations of 100 )lM, revealed a second, but weaker compound (9b; Figure 3b ) that caused similar phenotypic effects to those of synstab A (data not shown). The analog of synstab A lacking the terminal sulphonamide group, which had no effect on the ill vitro polymerization of tubulin, also had no observable effect on cells up to 100 )lM (data not shown). Because a 2 h treatment with synstab A followed by its removal by washing restored the normal microtubule staining pattern in both interphase ( Figure Sf (Figure 9d ) had fully replicated chromosomes (4N DNA content) and increased TG-3 staining. In addition, total cell extracts derived from cells treated with taxol, or with synstab A at concentrations that do not affect viability, showed by immunoblotting increased TG-3-reactivity ( Figure 10 ). As shown in Figure 4b , treatment of cells with synstab A at concentrations greater than 30 )lM does not result in a dose-dependent increase in TG-3 reactivity even though the maximum signal is less than that of either taxol or nocodazole (Figure 4a ). This suggests that at high concentrations either synstab A is less effective at inducing a mitotic arrest or it reduces cellular viability. In support of the latter notion, treatment of cells with synstab A for 24 h, but not with the analog lacking the sulphonamide group, reduced the viability of As49 cells by more than 80% at concentrations above 50 )lM, as measured by the reduction of the tetrazolium salt MTS (data not shown).
Taxol is thought to stabilize microtubules by counteracting the effects of GTP hydrolysis through its binding to a globular domain on ~ tubulin [21] . To address whether synstab A mimics the taxol mechanism of microtubule stabilization, we determined whether synstab A could compete with fluorescently labeled (Oregon Green) taxol (OGtx) for binding to microtubules previously stabilized with guanyIyl-a,~-methylene diphosphonate (GMPCPP, a nonhydrolysable analogue of GTP). Using a fluorescent microscopy assay, an equivalent concentration of DMSO had no effect (Figure 11a ), whereas synstab A displaced OGtx from the microtubules when added at a concentration of sOO)lM (Figure 11 b) . In the same assay, unlabeled taxol caused a similar displacement when added at a concentration of 1 )lM (data not shown). This mutually exclusive binding of synstab A and OGtx is consistent with the observed taxol-like effects of synstab A on cells ( Figure Se, h) , and suggests that the effects of synstab A are either because it binds to the same or overlapping sites on microtubules as taxol, or as a result of its ability to inducc a conformational change that prevents taxol binding. Because the addition of synstab A did not decrease the stability of GMPCPP-stabilized microtubules (Figure 10d) , and because synstab A did not alter the overall microtubule Given the similarities between the effects of synstab A and taxol on cells, and synstab A's ability to compete with taxol for binding to microtubules, we next determined whether synstab A treatment mimics other properties of known microtubule stabilizers. Because taxol and discodermolide different than that either of taxol or of discodermolide, or that the stabilization of microtubules upon treatment with synstab A is sufficient to perturb interphase and mitotic microtubule dynamics, but not sufficient to counteract the destabilizing effects of cold-induced depolymerization due to differences in binding affinity or cell permeability.
Group Ill: small molecules targeting mitotic machinery other than tubulin
To begin to determine the mechanism of action of the 86 remaining group III compounds, each compound was tested in a TG-3 cytoblot assay using cells that had previously been arrested in interphase by the histone deacetylase inhibitor trichostatin A [22] or the topoisomerase II inhibitor ICRF-193 [23] . Under these conditions, none of the group IH compounds stimulated cells to accumulate in mitosis, indicating that they require active cell-cycle progression to achieve their effects (data not shown).
Visual comparison of the chemical structures of group III compounds to those of group I compounds revealed that seven of 86 compounds show close structural homology to compounds that act as destabilizers of purified tubulin in vitro. Furthermore, although a number of these compounds had no observable effect on interphase cells, the effects of these compounds on microtubule organization in mitotic cells are similar to those observed for known weak microtubule depolymerizers (e.g., Figure 6c,d ). This suggests that a subset of compounds in group III are likely to be weak microtubule destabilizers, ineffective at destabilizing purified microtubules under the conditions used to identify compounds in group 1.
As observed with the variation in strength of microtubule depolymerization, the phenotype induced by many of the
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Figure 11
Mutually exclusive binding of synstab A and taxol to bovine brain microtubules. Fluorescence microscopy was used to visualize the binding of an Oregon-Green-Iabeled taxol derivative (OGtx) to TMRlabeled (red), GMPCPP-stabilized microtubules. When incubated in the presence 0(5% DMSO, but in absence of a competitor, the OGtx signal (a) colocalizes with the TMR signal from microtubules (c).
In contrast, when incubated in the presence of synstab A (500 flM), the OGtx signal (b) does not colocalize with the TMR signal from microtubules (d).
group IH compounds, in terms of chromosome distribution, microtubule morphology and actin distribution in interphase and mitotic cells, depended upon both the concentration tested and duration of treatment. Treatment with 12 group III compounds at -50 IlM led to cell death or detachment after 4 h; these compounds were not examined further in this study. Given the similarity between aspects of mitotic mechanisms and apoptosis, these compounds may target components common to both pathways [24, 25] .
As a more stringent test of whether compounds had visible effects on chromosomes and the cytoskeleton, cells were treated for 4 h with of each of the remaining group III compounds at -100 IlM. Under these conditions, 69 compounds either had no observable effect on interphase cells (although still increased the number of apparently normal mitotic cells) or caused disorganization of otherwise straight microtubules in interphase cells and partially or completely disrupted spindles and chromosome distribution in mitotic cells. The compounds that produced the latter effects may target cellular regulators of microtubule dynamics, such as the centrosome that nucleates microtubules or the microtubule-associated proteins that can either stabilize or destabilize micro tubules in cells [26] . The similarity in phenotype of these compounds to weak destabilizers, however, makes it difficult to determine their mechanism of action without further tests of resynthesized compounds. In general, those compounds that increased the number of cells in mitosis without an obvious morphological effect did so weakly, even at high concentrations, compared with compounds that were found to directly target microtubules (e.g., Figure 3 ). These compounds may affect the activity of cell-cycle regulators, the activity of which is required for exit from mitosis (e.g., the activity of the anaphase-promoting complex CDCS,14,1S,20) [27] . On the basis of the localization of MAD2 and the phosphorylation status of the kinetochore (the macromolecular structures that links mitotic chromosomes to microtubules) epitope 3F3 [28] , it should be possible, in future studies, to determine whether the action of these compounds involves the activation of the spindle assembly checkpoint or some other mechanism.
From fluorescence microscopy of cells stained for microtubules, chromatin and actin, the remaining five compounds Chemical structures of mitosis-specific smallmolecule inhibitors that do not interact directly with microtubules and have no observable morphological effect on the cytoskeleton or chromatin of interphase cells. Compound 10 (monastrol) is an inhibitor of the kinesin-related motor protein Eg5 [29] . The cellular targets of compounds 11-14 remain unknown.
(10-14; Figure 12 ) were determined to be mitosis specific. Phenotypically, all five compounds had no observable effect upon interphase cells, but disrupted mitotic spindle morphology, altered chromosome distribution, or both, in mitotic cells. As discussed by Mayer et al. [29] , the unique mono polar phenotype of one of these compounds (10, named monastrol) led to the discovery that monastrol specifically inhibits the kinesin-related protein EgS. Treatment of BS-C-1 cells with compound 11 caused a similar monopolar phenotype as monastrol (data not shown), suggesting that 11 targets EgS or another component of the pathway required for spindle bipolarity. The cellular targets of the remaining three compounds remain unknown. In support of the hypothesis that each of these compounds target different components of the mitotic machinery, the phenotypic effects upon treatment of cells with these compounds were each distinct ( Figure 13 ). For example, treatment with compound 12 (Figure 13b ) caused the formation of a double spindle and minor chromosome misalignment, whereas compound 14 had no apparent effect on the mitotic spindle but caused severe chromosome misalignment ( Figure Bc) . This later phenotype suggests that compound 14 may target a component of the kinetochore and thereby prevent the alignment of chromosomes at the metaphase plate.
Future directions and challenges
Since the first description in 1889 of the effects of colchicine on mitosis, small molecules have played an essential role in the dissecting of the molecular mechanisms of chromosome segregation [30] . Future work from this screen will be aimed at the identification of the cellular targets of compounds 11-14 using biochemical or genetic methods. The success of the first approach is dependent upon both the specificity of the compound and the affinity, whereas the success of the latter approach depends on specificity and on the availability of existing mutant phenotypes to match observed phenotypic defects. In this regard, comparison of the effects of these compounds to known mutants of yeast and to developing embryos of the nematode CaetlOrhabditis elegalls may provide a means either of identifying the exact target or of suggesting a mechanism of action [31] . This comparison can be based upon the observation of cellular morphology, the use of DNA microarrays and proteome-wide analysis.
One of the main challenges in high-throughput screening is to obtain the largest amount of useful information while using the smallest amount of compound. In this regard, a negative result obtained with a compound in one assay may be highly instructive in the context of another assay. Often the amount of compound available to validate whether its mechanism is distinct from previously known compounds is limited. In the case at hand, our ability to assess with a small amount of compound whether compounds targeted tubulin directly, using purified tubulin from bovine brain, was instrumental to the identification of compounds affecting the mitotic machinery through novel mechanisms.
Significance
Although the discovery of small-molecule inhibitors of protein-protein interactions is generally demanding, we noted the significant occurrence (-0.3% of compounds screened) of direct inhibitors of aI~ tubulin interactions in this study. This illustrates the use of a system-based, phenotype-directed screen to identify components in a pathway that are most easily targeted by small molecules. It also suggests that the toxicity associated with many compounds may be due to their ability to destabilize microtubules. Small molecules capable of stabilizing protein-protein interactions are of interest both from the perspective of understanding the molecular basis of protein-protein interactions and in the specific case of aI~ tubulin, because of the demonstrated use of taxol as an anticancer agent. Although synstab A shares many of the functional properties of taxol, it does not share structural features of known stabilizers of microtubules both 285 natural (taxoids, discodermolide, epothilone and eleutherobin) and synthetic (e.g., GS-164 [32] ). The ease with which synstab A was identified and its simple structure suggests to us that screening-based approaches to the discovery of taxol-like compounds will prove more effective than design-based approaches using 'pharmacophore' models [33, 34] . In the context of other complex cellular processes, these results suggests that cell-based assays, initially using an antibody to select for small-molecule-induced post-translational modifications, in conjunction with directed cytology and in vitro assays, will provide a fruitful means of exploring many biological processes.
Materials and methods
Cell cultures
A549 (human, lung carcinoma) and BS,C'l (African green monkey, kidney epithelial) cells were maintained at 37°C with 5% CO 2 in Dulbeco's modified eagle medium containing 10% fetal bovine serum, 100 units/ml penicillin G sodium, 100 Ilg/ml streptomycin sulphate and 2 mM glutamine (DMEM+; 0ibcoBRL).
TG-3 cytob!ot assay
Cells were seeded in 50 III of DMEM+ at a density of 4,000 cells per well of 384-well assay plates (Nalge Nunc, white, tissue culture treated) and cultured for 12 h at 37°C with 5% CO 2 • Library compounds (Diverse E set, Chembridge Corp.) dissolved in DMSO (5 mg/ml) were arrayed in 384-well plates and 50-200 nl of each compound was pin-transferred into 384-well assay plates. After 22-24 h, the percentage of cells in mitosis was assayed using the TG-3 mAb (11-13) as described [9] . Data were collected on an Analyst plate reader (UL Biosystems) with 0.2 s integration time. After two rounds of screening, ·compounds that increased TG-3 reactivity by 2.5 times or greater than control cells treated with DMSO were chosen for further analysis. To test for the requirement of active cell-cycle progression, cells were pretreated for 4 h, with either 300 nM trichostatin or 14 IlM ICRF-193, and group 1/1 compounds were added to a final concentration of -50 IlM. After 16-18 h, a TG-3 cytoblot assay was performed.
In vitro tubulin polymerization and taxo! competition assays
Purification of bovine tubulin and labeling of tubulin with tetramethylrhodamine (TMR) or Oregon Green (OG) fluorescent dye were performed as described [35] (see also hllp:lliccbweb.med.harvard.edu/ mitchisonlab/Pages/tubprep.html for more details). The extent of microtubule polymerization was determined in the presence of each compound at -50IlM using a standard in vitro tubulin polymerization assay (see hllp:lliccbweb.med.harvard.edu/mitchisonlab/Pages/poly.html for more details). After incubation for 20 min at 37°C, samples of reactions were spoiled on a glass slide and the extent of tubulin polymerization was visually assessed using fluorescence microscopy of OG-Iabeled microtubules. To quantitatively assess the effect of synstab A on the dynamics of microtubule polymerization, either synstab A (100 IlM), or an equivalent concentrations of DMSO, was added to 10 IlM tubulin and incubated at 37°C, in the presence of 1 mM GTP, in degassed PEM buffer (80 mM PIPES, pH 6.9, 1 mM EGTA, 1 mM MgCI 2 ). After 2 min, the optical density of the sample (340 nm) was measured at 30 s intervals using a Hewlett Packard 8452A diode array spectrophotometer. For competition experiments between synstab A and taxol, 500llM synstab A, or an equivalent concentration of DMSO (5%), was added to TMR-Iabeled, GMPCPP-stabilized microtubules (400 nM) in PEM buffer containing 240 nM of a fluorescently labeled (OG) taxol derivative (OGtx) (RF, unpublished results). Following incubation at room temperature for 1 0 min, 1.5 III samples of each reaction were spoiled onto a glass slide, covered with a coverslip and the localization of OGtx to the GMPCPP-stabilized, TMR-Iabeled microtubules was visualized using a Nikon E-800 fluorescence microscope. Control treatments in the absence of DMSO showed OGtx staining of TMR-Iabeled microtubules, whereas the addition of 1 ~M unlabeled taxol prevented the co-localization of OGtx to TMR-Iabeled microtubules.
Immunofluorescence and negative stain electron microscopy SS-C-l cells were seeded on glass coverslips at 80-90% confluency and compounds in DMSO were added to final concentrations as indicated. Cells were fixed with 0.2% glutaraldehyde and then stained for microtubules with an anti-a-tubulin antibody (Sigma), for chromatin with Hoecsht 33342 dye (Molecular Probes), and for actin with tetramethyl rhodamine isothiocyanate-conjugated phalloidin (Sigma). Images were obtained using a Nikon E-800 or leitz microscope. For electron microscopy of microtubules, samples of tubulin after polymerization in the presence of either synstab A (1 00 ~M) or an equivalent concentration of DMSO were spotted on to carbon-coated copper grids (200 mesh) and negatively stained for 1 min with 0.5% (w/v) uranyl acetate. After washing with 5 mM EGTA, images were obtained under low (x 4000) and high magnification (x 50,000).
